Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
CC transcript
|
|
Pernix Sleep, Inc. (SOMX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2011 |
BW
| Somaxon and Paladin Announce Silenor® Ex-US Collaboration |
| 05/03/2011 |
BW
| Somaxon Pharmaceuticals Reports First Quarter 2011 Financial Results |
| 04/25/2011 |
BW
| Somaxon Pharmaceuticals to Report First Quarter 2011 Results and Conduct Conference Call on Tuesday, May 3 |
| 03/29/2011 |
BW
| Somaxon Pharmaceuticals Announces Issuance of Patent Relating to Pharmacokinetics (Food Effect) of Silenor |
| 03/03/2011 |
BW
| Somaxon Reports Financial Results for Full Year and Fourth Quarter Ended December 31, 2010 |
| 02/28/2011 |
BW
| Somaxon Pharmaceuticals to Present at Upcoming Investor Conferences |
| 02/23/2011 |
BW
| Somaxon Pharmaceuticals to Report Full Year and Fourth Quarter Ended December 31, 2010 Financial Results and Conduct Conference Call on Thursday, March 3 |
| 02/22/2011 |
BW
| Somaxon Pharmaceuticals Receives Notice of Allowance for Patent Application Relating to Pharmacokinetics of Silenor |
| 11/30/2010 |
BW
| Somaxon Pharmaceuticals Awakens NASDAQ Stock Market by Ringing Opening Bell |
| 11/24/2010 |
BW
| Somaxon Announces Closing of Public Offering of Common Stock |
| 11/23/2010 |
BW
| Somaxon Pharmaceuticals to Present at Piper Jaffray 22nd Annual Healthcare Conference |
| 11/19/2010 |
BW
| Somaxon Announces Pricing of Public Offering of Common Stock |
| 11/18/2010 |
BW
| Somaxon Announces Proposed Public Offering of Common Stock |
| 11/09/2010 |
BW
| Somaxon Pharmaceuticals Reports Third Quarter 2010 Financial Results |
| 11/02/2010 |
BW
| Somaxon Pharmaceuticals Awarded Grant for Silenor under the Qualifying Therapeutic Discovery Project Program |
| 10/27/2010 |
BW
| Somaxon Pharmaceuticals to Report Third Quarter 2010 Results and Conduct Conference Call on Tuesday, November 9 |
| 10/18/2010 |
BW
| Somaxon Pharmaceuticals Announces Paragraph IV ANDA Filing for Silenor |
| 09/20/2010 |
BW
| Somaxon Pharmaceuticals Appoints Faheem Hasnain to Its Board of Directors |
| 09/14/2010 |
BW
| Somaxon Pharmaceuticals to Present at the UBS Global Life Sciences Conference |
| 08/11/2010 |
BW
| Somaxon Pharmaceuticals Reports Second Quarter 2010 Financial Results |
| 08/04/2010 |
BW
| Somaxon Pharmaceuticals to Report Second Quarter 2010 Results and Conduct Conference Call on Wednesday, August 11 |
| 07/29/2010 |
BW
| Somaxon Pharmaceuticals to Present at the BMO Capital Markets 10th Annual Focus on Healthcare Conference |
| 07/21/2010 |
BW
| Somaxon Pharmaceuticals Announces Acceptance of Phase 3 Clinical Trial Data for Publication in Sleep and Sleep Medicine |
| 07/14/2010 |
BW
| Somaxon Pharmaceuticals Establishes Silenor Commercial Team |
| 06/28/2010 |
BW
| Somaxon Pharmaceuticals Added to Russell 3000® Index, Russell 2000® Index, Russell Global® Index and Russell Microcap® Index |
| 05/03/2010 |
BW
| Somaxon Pharmaceuticals to Report First Quarter 2010 Results and to Conduct Conference Call on Tuesday, May 11, 2010 |
| 04/12/2010 |
BW
| Somaxon Pharmaceuticals Appoints Chief Financial Officer and Announces Senior Leadership Promotions |
| 03/31/2010 |
BW
| Somaxon Announces Completion of Public Offering of Common Stock |
| 03/25/2010 |
BW
| Somaxon Announces Pricing of Public Offering of Common Stock |
| 03/22/2010 |
BW
| Somaxon Announces Proposed Public Offering of Common Stock |
| 03/18/2010 |
BW
| Somaxon Reports 2009 Full Year Financial Results |
| 03/18/2010 |
BW
| Somaxon Announces FDA Approval of Silenor® (doxepin) for the Treatment of Insomnia |
|
|